Sickle-hemoglobin C (Hb S-C) disease occurs in individuals who have one gene for sickle cell anemia and one gene for hemoglobin C disease. The mutated genes affect the production of hemoglobin, or the material that makes blood red. Hb S-C disease is more common than other hemoglobin disorders because it is heterozygous. This means that both parents do not have to have a mutated gene in order to produce a child with the disorder. Instead, the disorder occurs when one parent passes on the gene for sickle cell anemia and the other passes on the gene for hemoglobin C.
Mary Reed, MD
- internal medicine
Location and Office HoursVia Christi Cancer Center
1102 E Centennial
Pittsburg, KS 66762
- What causes sickle-hemoglobin C (Hb S-C) disease?
How do drugs treat chronic myeloproliferative disorders?
Drugs used to treat chronic myeloproliferative disorders vary, depending on which type is being treated and whether there are any related symptoms. Chemotherapy, for example, uses drugs to kill cancer cells in the bone marrow. Other drugs reduce the number of blood platelets and white cells in the body or treat anemia. Which drug your doctor prescribes depends on the types of symptoms you are experiencing.
What are the long-term treatments for hypokalemia?
Potassium supplementation is the usual treatment for hypokalemia. The underlying cause of the low blood levels of potassium must be treated. Individuals should eat a diet with potassium-rich foods.
See all Blood Basics questions